Purdue Pharma L.P. v. United States ex rel. May
- Case Date: 4/24/2014
- Project Name: Civil Justice Reform
On June 2, 2015, the U.S. Supreme Court declined to review an appeals court decision that undermines the ability of defendants to contest qui tam lawsuits filed against them under the False Claims Act (FCA). The decision was a setback for WLF, which filed a brief urging the Court to grant review. WLF argued that private individuals should not be permitted to file suit in the name of the federal government against a company doing business with the government, if they have no personal knowledge of wrongdoing and are simply basing their claims on publicly available reports. The FCA often gives rise to parasitic lawsuits by individuals who have no unique knowledge of fraudulent activity but are attracted by the generous bounties available under the FCA. Congress adopted statutes designed to prevent parasitic lawsuit, including one known as the “public disclosure bar.” WLF charged that the appeals court interpreted the statutory bar in a manner that deprives it of all teeth.
More Information and Downloads:
4/24/2014: Download the Brief